Jacobs Levy Equity Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-101,397
| Closed | -$1.07M | – | 1193 |
|
|
2024
Q4 | $1.07M | Sell |
101,397
-551,651
| -84% | -$5.82M | ﹤0.01% | 705 |
|
|
2024
Q3 | $9.47M | Buy |
653,048
+288,021
| +79% | +$4.18M | 0.04% | 331 |
|
|
2024
Q2 | $3.11M | Buy |
365,027
+87,321
| +31% | +$743K | 0.01% | 526 |
|
|
2024
Q1 | $2.84M | Buy |
277,706
+257,589
| +1,280% | +$2.63M | 0.01% | 534 |
|
|
2023
Q4 | $110K | Buy |
+20,117
| New | +$110K | ﹤0.01% | 951 |
|
|
2023
Q3 | – | Sell |
-37,903
| Closed | -$254K | – | 1058 |
|
|
2023
Q2 | $254K | Sell |
37,903
-257,368
| -87% | -$1.72M | ﹤0.01% | 905 |
|
|
2023
Q1 | $1.92M | Sell |
295,271
-3,345
| -1% | -$21.8K | 0.01% | 581 |
|
|
2022
Q4 | $2.55M | Sell |
298,616
-152,218
| -34% | -$1.3M | 0.02% | 508 |
|
|
2022
Q3 | $2.38M | Buy |
+450,834
| New | +$2.38M | 0.02% | 528 |
|